Top 15 Trending Stocks On WallStreetBets As Of Monday, Dec. 12, 2022 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Team Announces One-For-Ten Reverse Stock Split
Team, Inc. (NYSE:TISI) ("TEAM" or the "Company"), a global leading provider of integrated, digitally-enabled asset performance assurance and optimization solutions, today announced that the Board
Nasdaq Halts Pingtan Marine Enterprise
The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted today in Pingtan Marine Enterprise Ltd. (NASDAQ:PME) at 09:14:21 A.M. Eastern Time for "additional information requested" from
Timber Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards
Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE:TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan
Puhui Wealth Investment Management Announces Effectiveness Of Share Consolidation At Ratio Of 1-For-6
Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) ("Puhui" or the "Company"), a China-based third-party wealth management service provider with a focus on wealth management services for high
Top 15 Trending Stocks On WallStreetBets As Of Friday, Dec. 9, 2022 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Nvidia (NVDA)
Lululemon Athletica (LULU)
Carvana (CVNA)
Apple (AAPL)
Amazon (AMZN)
Netflix (NFLX)
DocuSign
Datopotamab Deruxtecan Showed Encouraging, Durable Efficacy In Patients With Heavily Pretreated HR Positive, HER2 Low Or Negative Metastatic Breast Cancer
First results for Daiichi Sankyo and AstraZeneca's TROP2 directed ADC in this setting reported from TROPION-PanTumor01 phase 1 trial
Pivotal TROPION-Breast01 phase 3 trial is ongoing, evaluating datopotamab
New Study Published In The American Journal Of Pathology Suggests Obeticholic Acid (OCA) May Improve Cognitive Impairment Associated With Cholestatic Liver Disease
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, is pleased to share
‘Walmart Plans to Offer Buy Now, Pay Later Loans Through its Fintech Venture’ -Earlier Report From The Information
https://www.theinformation.com/articles/walmart-plans-to-offer-buy-now-pay-later-loans-through-its-fintech-venture